Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84

United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

27 insiders · 499 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael Morrissey

President and CEO

—

$58.19M (59) scheduled

−$58.19M

3,810,385

1.54%

$204.47M

+465.6%

Patrick J. Haley

EVP, Commercial

—

$35.85M (70)

−$35.85M

357,638

0.1443%

$19.19M

+68.7%

Gisela Schwab

Pres, Prod Dev & Med Aff & CMO

—

$34.69M (36) scheduled

−$34.69M

689,078

0.2781%

$36.98M

+318.0%

Jeffrey Hessekiel

EVP & General Counsel

—

$28.18M (41) scheduled

−$28.18M

693,396

0.2798%

$37.21M

+173.0%

Peter Lamb

EVP, Scientific Strategy & CSO

—

$27.46M (26) scheduled

−$27.46M

410,958

0.1659%

$22.05M

+458.4%

Christopher J. Senner

EVP and CFO

—

$24.02M (17) scheduled

−$24.02M

952,317

0.3843%

$51.10M

+717.9%

George A Scangos

Director

—

$23.44M (42)

−$23.44M

714,717

0.2884%

$38.35M

−45.3%

Stelios Papadopoulos

Director

—

$16.81M (16)

−$16.81M

1,197,595

0.4833%

$64.26M

−3.3%

Dana Aftab

EVP, Research and Development

—

$16.67M (13)

−$16.67M

594,741

0.2400%

$31.91M

+131.3%

David Edward Johnson

Director

$16.46M (5)

$2.60M (1)

+$13.85M

1,571,438

0.6342%

$84.32M

+72.5%

George Poste

Director

—

$12.00M (15) scheduled

−$12.00M

127,199

0.0513%

$6.83M

+64.0%

Lance Willsey

Director

—

$10.20M (13)

−$10.20M

424,415

0.1713%

$22.77M

−25.3%

Vincent T Marchesi

Director

—

$8.70M (12) scheduled

−$8.70M

93,989

0.0379%

$5.04M

−21.7%

Julie Smith

Director

—

$8.07M (6) scheduled

−$8.07M

28,957

0.0117%

$1.55M

+3,695%

Jack L Wyszomierski

Director

—

$7.73M (14) scheduled

−$7.73M

284,384

0.1148%

$15.26M

+317.5%

Charles Cohen

Director

—

$7.42M (8)

−$7.42M

261,375

0.1055%

$14.03M

+5.3%

Alan M Garber

Director

—

$7.13M (14) scheduled

−$7.13M

35,703

0.0144%

$1.92M

−39.7%

Carl B Feldbaum

Director

—

$6.83M (14) scheduled

−$6.83M

18,701

0.0075%

$1.00M

−61.6%

Amy C. Peterson

EVP Prod Dev & Med Aff & CMO

—

$3.31M (1) scheduled

−$3.31M

465,393

0.1878%

$24.97M

—

Maria C Freire

Director

—

$2.92M (4) scheduled

−$2.92M

109,186

0.0441%

$5.86M

—

Mary C Beckerle

Director

—

$2.36M (6) scheduled

−$2.36M

16,079

0.0065%

$862.80K

—

Bob Oliver

Director

—

$2.02M (3) scheduled

−$2.02M

29,487

0.0119%

$1.58M

—

Sue Gail Eckhardt

Director

—

$1.87M (6) scheduled

−$1.87M

16,079

0.0065%

$862.80K

—

Brenda Hefti

SVP and General Counsel

—

$1.15M (2) scheduled

−$1.15M

106,762

0.0431%

$5.73M

+17.8%

Tomas J. Heyman

Director

—

$201.25K (1)

−$201.25K

50,649

0.0204%

$2.72M

—

Vicki L Goodman

EVP, Prod Dev & Med Aff &CMO

—

—

—

307,654

0.1242%

$16.51M

—

Jacqueline Wright

Director

—

—

—

51,756

0.0209%

$2.78M

—